MET and breast cancer: In this study, we identified eight stable BC-guided KGs EGFR, FN1, EZH2, MET, CDK1, AURKA, TOP2A, and BIRC5 using well-established bioinformatics and network-based tools and highlighted their pathogenetic processes, regulatory factors, prognostic power, and drug molecules.